[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Anti-Inflammatory and Analgesic Gel Market Growth 2024-2030

May 2024 | 109 pages | ID: G0865515EAC0EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

The global Anti-Inflammatory and Analgesic Gel market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Anti-Inflammatory and Analgesic Gel Industry Forecast” looks at past sales and reviews total world Anti-Inflammatory and Analgesic Gel sales in 2023, providing a comprehensive analysis by region and market sector of projected Anti-Inflammatory and Analgesic Gel sales for 2024 through 2030. With Anti-Inflammatory and Analgesic Gel sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-Inflammatory and Analgesic Gel industry.

This Insight Report provides a comprehensive analysis of the global Anti-Inflammatory and Analgesic Gel landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-Inflammatory and Analgesic Gel portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-Inflammatory and Analgesic Gel market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-Inflammatory and Analgesic Gel and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-Inflammatory and Analgesic Gel.

United States market for Anti-Inflammatory and Analgesic Gel is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Anti-Inflammatory and Analgesic Gel is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Anti-Inflammatory and Analgesic Gel is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Anti-Inflammatory and Analgesic Gel players cover Novartis, Pfizer, GlaxoSmithKline, Johnson & Johnson, Sanofi, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Inflammatory and Analgesic Gel market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Prescription Pain Relief Gel
  • Over-the-Counter Pain Relief Gel
Segmentation by Application:
  • Hospital
  • Home Care
  • Other
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Novartis
  • Pfizer
  • GlaxoSmithKline
  • Johnson & Johnson
  • Sanofi
  • Sun Pharmaceutical Industries
  • AdvaCare Pharma
  • Topical BioMedics
  • Health & Beyond
  • Troy Healthcare
  • Glydex Pharmaceutical
  • Microwin
Key Questions Addressed in this Report

What is the 10-year outlook for the global Anti-Inflammatory and Analgesic Gel market?

What factors are driving Anti-Inflammatory and Analgesic Gel market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Anti-Inflammatory and Analgesic Gel market opportunities vary by end market size?

How does Anti-Inflammatory and Analgesic Gel break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Anti-Inflammatory and Analgesic Gel Annual Sales 2019-2030
  2.1.2 World Current & Future Analysis for Anti-Inflammatory and Analgesic Gel by Geographic Region, 2019, 2023 & 2030
  2.1.3 World Current & Future Analysis for Anti-Inflammatory and Analgesic Gel by Country/Region, 2019, 2023 & 2030
2.2 Anti-Inflammatory and Analgesic Gel Segment by Type
  2.2.1 Prescription Pain Relief Gel
  2.2.2 Over-the-Counter Pain Relief Gel
2.3 Anti-Inflammatory and Analgesic Gel Sales by Type
  2.3.1 Global Anti-Inflammatory and Analgesic Gel Sales Market Share by Type (2019-2024)
  2.3.2 Global Anti-Inflammatory and Analgesic Gel Revenue and Market Share by Type (2019-2024)
  2.3.3 Global Anti-Inflammatory and Analgesic Gel Sale Price by Type (2019-2024)
2.4 Anti-Inflammatory and Analgesic Gel Segment by Application
  2.4.1 Hospital
  2.4.2 Home Care
  2.4.3 Other
2.5 Anti-Inflammatory and Analgesic Gel Sales by Application
  2.5.1 Global Anti-Inflammatory and Analgesic Gel Sale Market Share by Application (2019-2024)
  2.5.2 Global Anti-Inflammatory and Analgesic Gel Revenue and Market Share by Application (2019-2024)
  2.5.3 Global Anti-Inflammatory and Analgesic Gel Sale Price by Application (2019-2024)

3 GLOBAL BY COMPANY

3.1 Global Anti-Inflammatory and Analgesic Gel Breakdown Data by Company
  3.1.1 Global Anti-Inflammatory and Analgesic Gel Annual Sales by Company (2019-2024)
  3.1.2 Global Anti-Inflammatory and Analgesic Gel Sales Market Share by Company (2019-2024)
3.2 Global Anti-Inflammatory and Analgesic Gel Annual Revenue by Company (2019-2024)
  3.2.1 Global Anti-Inflammatory and Analgesic Gel Revenue by Company (2019-2024)
  3.2.2 Global Anti-Inflammatory and Analgesic Gel Revenue Market Share by Company (2019-2024)
3.3 Global Anti-Inflammatory and Analgesic Gel Sale Price by Company
3.4 Key Manufacturers Anti-Inflammatory and Analgesic Gel Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Anti-Inflammatory and Analgesic Gel Product Location Distribution
  3.4.2 Players Anti-Inflammatory and Analgesic Gel Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR ANTI-INFLAMMATORY AND ANALGESIC GEL BY GEOGRAPHIC REGION

4.1 World Historic Anti-Inflammatory and Analgesic Gel Market Size by Geographic Region (2019-2024)
  4.1.1 Global Anti-Inflammatory and Analgesic Gel Annual Sales by Geographic Region (2019-2024)
  4.1.2 Global Anti-Inflammatory and Analgesic Gel Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Anti-Inflammatory and Analgesic Gel Market Size by Country/Region (2019-2024)
  4.2.1 Global Anti-Inflammatory and Analgesic Gel Annual Sales by Country/Region (2019-2024)
  4.2.2 Global Anti-Inflammatory and Analgesic Gel Annual Revenue by Country/Region (2019-2024)
4.3 Americas Anti-Inflammatory and Analgesic Gel Sales Growth
4.4 APAC Anti-Inflammatory and Analgesic Gel Sales Growth
4.5 Europe Anti-Inflammatory and Analgesic Gel Sales Growth
4.6 Middle East & Africa Anti-Inflammatory and Analgesic Gel Sales Growth

5 AMERICAS

5.1 Americas Anti-Inflammatory and Analgesic Gel Sales by Country
  5.1.1 Americas Anti-Inflammatory and Analgesic Gel Sales by Country (2019-2024)
  5.1.2 Americas Anti-Inflammatory and Analgesic Gel Revenue by Country (2019-2024)
5.2 Americas Anti-Inflammatory and Analgesic Gel Sales by Type (2019-2024)
5.3 Americas Anti-Inflammatory and Analgesic Gel Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Anti-Inflammatory and Analgesic Gel Sales by Region
  6.1.1 APAC Anti-Inflammatory and Analgesic Gel Sales by Region (2019-2024)
  6.1.2 APAC Anti-Inflammatory and Analgesic Gel Revenue by Region (2019-2024)
6.2 APAC Anti-Inflammatory and Analgesic Gel Sales by Type (2019-2024)
6.3 APAC Anti-Inflammatory and Analgesic Gel Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Anti-Inflammatory and Analgesic Gel by Country
  7.1.1 Europe Anti-Inflammatory and Analgesic Gel Sales by Country (2019-2024)
  7.1.2 Europe Anti-Inflammatory and Analgesic Gel Revenue by Country (2019-2024)
7.2 Europe Anti-Inflammatory and Analgesic Gel Sales by Type (2019-2024)
7.3 Europe Anti-Inflammatory and Analgesic Gel Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Anti-Inflammatory and Analgesic Gel by Country
  8.1.1 Middle East & Africa Anti-Inflammatory and Analgesic Gel Sales by Country (2019-2024)
  8.1.2 Middle East & Africa Anti-Inflammatory and Analgesic Gel Revenue by Country (2019-2024)
8.2 Middle East & Africa Anti-Inflammatory and Analgesic Gel Sales by Type (2019-2024)
8.3 Middle East & Africa Anti-Inflammatory and Analgesic Gel Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-Inflammatory and Analgesic Gel
10.3 Manufacturing Process Analysis of Anti-Inflammatory and Analgesic Gel
10.4 Industry Chain Structure of Anti-Inflammatory and Analgesic Gel

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Anti-Inflammatory and Analgesic Gel Distributors
11.3 Anti-Inflammatory and Analgesic Gel Customer

12 WORLD FORECAST REVIEW FOR ANTI-INFLAMMATORY AND ANALGESIC GEL BY GEOGRAPHIC REGION

12.1 Global Anti-Inflammatory and Analgesic Gel Market Size Forecast by Region
  12.1.1 Global Anti-Inflammatory and Analgesic Gel Forecast by Region (2025-2030)
  12.1.2 Global Anti-Inflammatory and Analgesic Gel Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Anti-Inflammatory and Analgesic Gel Forecast by Type (2025-2030)
12.7 Global Anti-Inflammatory and Analgesic Gel Forecast by Application (2025-2030)

13 KEY PLAYERS ANALYSIS

13.1 Novartis
  13.1.1 Novartis Company Information
  13.1.2 Novartis Anti-Inflammatory and Analgesic Gel Product Portfolios and Specifications
  13.1.3 Novartis Anti-Inflammatory and Analgesic Gel Sales, Revenue, Price and Gross Margin (2019-2024)
  13.1.4 Novartis Main Business Overview
  13.1.5 Novartis Latest Developments
13.2 Pfizer
  13.2.1 Pfizer Company Information
  13.2.2 Pfizer Anti-Inflammatory and Analgesic Gel Product Portfolios and Specifications
  13.2.3 Pfizer Anti-Inflammatory and Analgesic Gel Sales, Revenue, Price and Gross Margin (2019-2024)
  13.2.4 Pfizer Main Business Overview
  13.2.5 Pfizer Latest Developments
13.3 GlaxoSmithKline
  13.3.1 GlaxoSmithKline Company Information
  13.3.2 GlaxoSmithKline Anti-Inflammatory and Analgesic Gel Product Portfolios and Specifications
  13.3.3 GlaxoSmithKline Anti-Inflammatory and Analgesic Gel Sales, Revenue, Price and Gross Margin (2019-2024)
  13.3.4 GlaxoSmithKline Main Business Overview
  13.3.5 GlaxoSmithKline Latest Developments
13.4 Johnson & Johnson
  13.4.1 Johnson & Johnson Company Information
  13.4.2 Johnson & Johnson Anti-Inflammatory and Analgesic Gel Product Portfolios and Specifications
  13.4.3 Johnson & Johnson Anti-Inflammatory and Analgesic Gel Sales, Revenue, Price and Gross Margin (2019-2024)
  13.4.4 Johnson & Johnson Main Business Overview
  13.4.5 Johnson & Johnson Latest Developments
13.5 Sanofi
  13.5.1 Sanofi Company Information
  13.5.2 Sanofi Anti-Inflammatory and Analgesic Gel Product Portfolios and Specifications
  13.5.3 Sanofi Anti-Inflammatory and Analgesic Gel Sales, Revenue, Price and Gross Margin (2019-2024)
  13.5.4 Sanofi Main Business Overview
  13.5.5 Sanofi Latest Developments
13.6 Sun Pharmaceutical Industries
  13.6.1 Sun Pharmaceutical Industries Company Information
  13.6.2 Sun Pharmaceutical Industries Anti-Inflammatory and Analgesic Gel Product Portfolios and Specifications
  13.6.3 Sun Pharmaceutical Industries Anti-Inflammatory and Analgesic Gel Sales, Revenue, Price and Gross Margin (2019-2024)
  13.6.4 Sun Pharmaceutical Industries Main Business Overview
  13.6.5 Sun Pharmaceutical Industries Latest Developments
13.7 AdvaCare Pharma
  13.7.1 AdvaCare Pharma Company Information
  13.7.2 AdvaCare Pharma Anti-Inflammatory and Analgesic Gel Product Portfolios and Specifications
  13.7.3 AdvaCare Pharma Anti-Inflammatory and Analgesic Gel Sales, Revenue, Price and Gross Margin (2019-2024)
  13.7.4 AdvaCare Pharma Main Business Overview
  13.7.5 AdvaCare Pharma Latest Developments
13.8 Topical BioMedics
  13.8.1 Topical BioMedics Company Information
  13.8.2 Topical BioMedics Anti-Inflammatory and Analgesic Gel Product Portfolios and Specifications
  13.8.3 Topical BioMedics Anti-Inflammatory and Analgesic Gel Sales, Revenue, Price and Gross Margin (2019-2024)
  13.8.4 Topical BioMedics Main Business Overview
  13.8.5 Topical BioMedics Latest Developments
13.9 Health & Beyond
  13.9.1 Health & Beyond Company Information
  13.9.2 Health & Beyond Anti-Inflammatory and Analgesic Gel Product Portfolios and Specifications
  13.9.3 Health & Beyond Anti-Inflammatory and Analgesic Gel Sales, Revenue, Price and Gross Margin (2019-2024)
  13.9.4 Health & Beyond Main Business Overview
  13.9.5 Health & Beyond Latest Developments
13.10 Troy Healthcare
  13.10.1 Troy Healthcare Company Information
  13.10.2 Troy Healthcare Anti-Inflammatory and Analgesic Gel Product Portfolios and Specifications
  13.10.3 Troy Healthcare Anti-Inflammatory and Analgesic Gel Sales, Revenue, Price and Gross Margin (2019-2024)
  13.10.4 Troy Healthcare Main Business Overview
  13.10.5 Troy Healthcare Latest Developments
13.11 Glydex Pharmaceutical
  13.11.1 Glydex Pharmaceutical Company Information
  13.11.2 Glydex Pharmaceutical Anti-Inflammatory and Analgesic Gel Product Portfolios and Specifications
  13.11.3 Glydex Pharmaceutical Anti-Inflammatory and Analgesic Gel Sales, Revenue, Price and Gross Margin (2019-2024)
  13.11.4 Glydex Pharmaceutical Main Business Overview
  13.11.5 Glydex Pharmaceutical Latest Developments
13.12 Microwin
  13.12.1 Microwin Company Information
  13.12.2 Microwin Anti-Inflammatory and Analgesic Gel Product Portfolios and Specifications
  13.12.3 Microwin Anti-Inflammatory and Analgesic Gel Sales, Revenue, Price and Gross Margin (2019-2024)
  13.12.4 Microwin Main Business Overview
  13.12.5 Microwin Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Anti-Inflammatory and Analgesic Gel Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Anti-Inflammatory and Analgesic Gel Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Prescription Pain Relief Gel
Table 4. Major Players of Over-the-Counter Pain Relief Gel
Table 5. Global Anti-Inflammatory and Analgesic Gel Sales by Type (2019-2024) & (K Units)
Table 6. Global Anti-Inflammatory and Analgesic Gel Sales Market Share by Type (2019-2024)
Table 7. Global Anti-Inflammatory and Analgesic Gel Revenue by Type (2019-2024) & ($ million)
Table 8. Global Anti-Inflammatory and Analgesic Gel Revenue Market Share by Type (2019-2024)
Table 9. Global Anti-Inflammatory and Analgesic Gel Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global Anti-Inflammatory and Analgesic Gel Sale by Application (2019-2024) & (K Units)
Table 11. Global Anti-Inflammatory and Analgesic Gel Sale Market Share by Application (2019-2024)
Table 12. Global Anti-Inflammatory and Analgesic Gel Revenue by Application (2019-2024) & ($ million)
Table 13. Global Anti-Inflammatory and Analgesic Gel Revenue Market Share by Application (2019-2024)
Table 14. Global Anti-Inflammatory and Analgesic Gel Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Anti-Inflammatory and Analgesic Gel Sales by Company (2019-2024) & (K Units)
Table 16. Global Anti-Inflammatory and Analgesic Gel Sales Market Share by Company (2019-2024)
Table 17. Global Anti-Inflammatory and Analgesic Gel Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Anti-Inflammatory and Analgesic Gel Revenue Market Share by Company (2019-2024)
Table 19. Global Anti-Inflammatory and Analgesic Gel Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Anti-Inflammatory and Analgesic Gel Producing Area Distribution and Sales Area
Table 21. Players Anti-Inflammatory and Analgesic Gel Products Offered
Table 22. Anti-Inflammatory and Analgesic Gel Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Anti-Inflammatory and Analgesic Gel Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Anti-Inflammatory and Analgesic Gel Sales Market Share Geographic Region (2019-2024)
Table 27. Global Anti-Inflammatory and Analgesic Gel Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Anti-Inflammatory and Analgesic Gel Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Anti-Inflammatory and Analgesic Gel Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Anti-Inflammatory and Analgesic Gel Sales Market Share by Country/Region (2019-2024)
Table 31. Global Anti-Inflammatory and Analgesic Gel Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Anti-Inflammatory and Analgesic Gel Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Anti-Inflammatory and Analgesic Gel Sales by Country (2019-2024) & (K Units)
Table 34. Americas Anti-Inflammatory and Analgesic Gel Sales Market Share by Country (2019-2024)
Table 35. Americas Anti-Inflammatory and Analgesic Gel Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Anti-Inflammatory and Analgesic Gel Sales by Type (2019-2024) & (K Units)
Table 37. Americas Anti-Inflammatory and Analgesic Gel Sales by Application (2019-2024) & (K Units)
Table 38. APAC Anti-Inflammatory and Analgesic Gel Sales by Region (2019-2024) & (K Units)
Table 39. APAC Anti-Inflammatory and Analgesic Gel Sales Market Share by Region (2019-2024)
Table 40. APAC Anti-Inflammatory and Analgesic Gel Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Anti-Inflammatory and Analgesic Gel Sales by Type (2019-2024) & (K Units)
Table 42. APAC Anti-Inflammatory and Analgesic Gel Sales by Application (2019-2024) & (K Units)
Table 43. Europe Anti-Inflammatory and Analgesic Gel Sales by Country (2019-2024) & (K Units)
Table 44. Europe Anti-Inflammatory and Analgesic Gel Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Anti-Inflammatory and Analgesic Gel Sales by Type (2019-2024) & (K Units)
Table 46. Europe Anti-Inflammatory and Analgesic Gel Sales by Application (2019-2024) & (K Units)
Table 47. Middle East & Africa Anti-Inflammatory and Analgesic Gel Sales by Country (2019-2024) & (K Units)
Table 48. Middle East & Africa Anti-Inflammatory and Analgesic Gel Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Anti-Inflammatory and Analgesic Gel Sales by Type (2019-2024) & (K Units)
Table 50. Middle East & Africa Anti-Inflammatory and Analgesic Gel Sales by Application (2019-2024) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Anti-Inflammatory and Analgesic Gel
Table 52. Key Market Challenges & Risks of Anti-Inflammatory and Analgesic Gel
Table 53. Key Industry Trends of Anti-Inflammatory and Analgesic Gel
Table 54. Anti-Inflammatory and Analgesic Gel Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Anti-Inflammatory and Analgesic Gel Distributors List
Table 57. Anti-Inflammatory and Analgesic Gel Customer List
Table 58. Global Anti-Inflammatory and Analgesic Gel Sales Forecast by Region (2025-2030) & (K Units)
Table 59. Global Anti-Inflammatory and Analgesic Gel Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Anti-Inflammatory and Analgesic Gel Sales Forecast by Country (2025-2030) & (K Units)
Table 61. Americas Anti-Inflammatory and Analgesic Gel Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Anti-Inflammatory and Analgesic Gel Sales Forecast by Region (2025-2030) & (K Units)
Table 63. APAC Anti-Inflammatory and Analgesic Gel Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Anti-Inflammatory and Analgesic Gel Sales Forecast by Country (2025-2030) & (K Units)
Table 65. Europe Anti-Inflammatory and Analgesic Gel Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Anti-Inflammatory and Analgesic Gel Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Middle East & Africa Anti-Inflammatory and Analgesic Gel Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Anti-Inflammatory and Analgesic Gel Sales Forecast by Type (2025-2030) & (K Units)
Table 69. Global Anti-Inflammatory and Analgesic Gel Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global Anti-Inflammatory and Analgesic Gel Sales Forecast by Application (2025-2030) & (K Units)
Table 71. Global Anti-Inflammatory and Analgesic Gel Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Novartis Basic Information, Anti-Inflammatory and Analgesic Gel Manufacturing Base, Sales Area and Its Competitors
Table 73. Novartis Anti-Inflammatory and Analgesic Gel Product Portfolios and Specifications
Table 74. Novartis Anti-Inflammatory and Analgesic Gel Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Novartis Main Business
Table 76. Novartis Latest Developments
Table 77. Pfizer Basic Information, Anti-Inflammatory and Analgesic Gel Manufacturing Base, Sales Area and Its Competitors
Table 78. Pfizer Anti-Inflammatory and Analgesic Gel Product Portfolios and Specifications
Table 79. Pfizer Anti-Inflammatory and Analgesic Gel Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Pfizer Main Business
Table 81. Pfizer Latest Developments
Table 82. GlaxoSmithKline Basic Information, Anti-Inflammatory and Analgesic Gel Manufacturing Base, Sales Area and Its Competitors
Table 83. GlaxoSmithKline Anti-Inflammatory and Analgesic Gel Product Portfolios and Specifications
Table 84. GlaxoSmithKline Anti-Inflammatory and Analgesic Gel Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. GlaxoSmithKline Main Business
Table 86. GlaxoSmithKline Latest Developments
Table 87. Johnson & Johnson Basic Information, Anti-Inflammatory and Analgesic Gel Manufacturing Base, Sales Area and Its Competitors
Table 88. Johnson & Johnson Anti-Inflammatory and Analgesic Gel Product Portfolios and Specifications
Table 89. Johnson & Johnson Anti-Inflammatory and Analgesic Gel Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Johnson & Johnson Main Business
Table 91. Johnson & Johnson Latest Developments
Table 92. Sanofi Basic Information, Anti-Inflammatory and Analgesic Gel Manufacturing Base, Sales Area and Its Competitors
Table 93. Sanofi Anti-Inflammatory and Analgesic Gel Product Portfolios and Specifications
Table 94. Sanofi Anti-Inflammatory and Analgesic Gel Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Sanofi Main Business
Table 96. Sanofi Latest Developments
Table 97. Sun Pharmaceutical Industries Basic Information, Anti-Inflammatory and Analgesic Gel Manufacturing Base, Sales Area and Its Competitors
Table 98. Sun Pharmaceutical Industries Anti-Inflammatory and Analgesic Gel Product Portfolios and Specifications
Table 99. Sun Pharmaceutical Industries Anti-Inflammatory and Analgesic Gel Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Sun Pharmaceutical Industries Main Business
Table 101. Sun Pharmaceutical Industries Latest Developments
Table 102. AdvaCare Pharma Basic Information, Anti-Inflammatory and Analgesic Gel Manufacturing Base, Sales Area and Its Competitors
Table 103. AdvaCare Pharma Anti-Inflammatory and Analgesic Gel Product Portfolios and Specifications
Table 104. AdvaCare Pharma Anti-Inflammatory and Analgesic Gel Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. AdvaCare Pharma Main Business
Table 106. AdvaCare Pharma Latest Developments
Table 107. Topical BioMedics Basic Information, Anti-Inflammatory and Analgesic Gel Manufacturing Base, Sales Area and Its Competitors
Table 108. Topical BioMedics Anti-Inflammatory and Analgesic Gel Product Portfolios and Specifications
Table 109. Topical BioMedics Anti-Inflammatory and Analgesic Gel Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Topical BioMedics Main Business
Table 111. Topical BioMedics Latest Developments
Table 112. Health & Beyond Basic Information, Anti-Inflammatory and Analgesic Gel Manufacturing Base, Sales Area and Its Competitors
Table 113. Health & Beyond Anti-Inflammatory and Analgesic Gel Product Portfolios and Specifications
Table 114. Health & Beyond Anti-Inflammatory and Analgesic Gel Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Health & Beyond Main Business
Table 116. Health & Beyond Latest Developments
Table 117. Troy Healthcare Basic Information, Anti-Inflammatory and Analgesic Gel Manufacturing Base, Sales Area and Its Competitors
Table 118. Troy Healthcare Anti-Inflammatory and Analgesic Gel Product Portfolios and Specifications
Table 119. Troy Healthcare Anti-Inflammatory and Analgesic Gel Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Troy Healthcare Main Business
Table 121. Troy Healthcare Latest Developments
Table 122. Glydex Pharmaceutical Basic Information, Anti-Inflammatory and Analgesic Gel Manufacturing Base, Sales Area and Its Competitors
Table 123. Glydex Pharmaceutical Anti-Inflammatory and Analgesic Gel Product Portfolios and Specifications
Table 124. Glydex Pharmaceutical Anti-Inflammatory and Analgesic Gel Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Glydex Pharmaceutical Main Business
Table 126. Glydex Pharmaceutical Latest Developments
Table 127. Microwin Basic Information, Anti-Inflammatory and Analgesic Gel Manufacturing Base, Sales Area and Its Competitors
Table 128. Microwin Anti-Inflammatory and Analgesic Gel Product Portfolios and Specifications
Table 129. Microwin Anti-Inflammatory and Analgesic Gel Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Microwin Main Business
Table 131. Microwin Latest Developments

LIST OF FIGURES

Figure 1. Picture of Anti-Inflammatory and Analgesic Gel
Figure 2. Anti-Inflammatory and Analgesic Gel Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-Inflammatory and Analgesic Gel Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Anti-Inflammatory and Analgesic Gel Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Anti-Inflammatory and Analgesic Gel Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Anti-Inflammatory and Analgesic Gel Sales Market Share by Country/Region (2023)
Figure 10. Anti-Inflammatory and Analgesic Gel Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Prescription Pain Relief Gel
Figure 12. Product Picture of Over-the-Counter Pain Relief Gel
Figure 13. Global Anti-Inflammatory and Analgesic Gel Sales Market Share by Type in 2023
Figure 14. Global Anti-Inflammatory and Analgesic Gel Revenue Market Share by Type (2019-2024)
Figure 15. Anti-Inflammatory and Analgesic Gel Consumed in Hospital
Figure 16. Global Anti-Inflammatory and Analgesic Gel Market: Hospital (2019-2024) & (K Units)
Figure 17. Anti-Inflammatory and Analgesic Gel Consumed in Home Care
Figure 18. Global Anti-Inflammatory and Analgesic Gel Market: Home Care (2019-2024) & (K Units)
Figure 19. Anti-Inflammatory and Analgesic Gel Consumed in Other
Figure 20. Global Anti-Inflammatory and Analgesic Gel Market: Other (2019-2024) & (K Units)
Figure 21. Global Anti-Inflammatory and Analgesic Gel Sale Market Share by Application (2023)
Figure 22. Global Anti-Inflammatory and Analgesic Gel Revenue Market Share by Application in 2023
Figure 23. Anti-Inflammatory and Analgesic Gel Sales by Company in 2023 (K Units)
Figure 24. Global Anti-Inflammatory and Analgesic Gel Sales Market Share by Company in 2023
Figure 25. Anti-Inflammatory and Analgesic Gel Revenue by Company in 2023 ($ millions)
Figure 26. Global Anti-Inflammatory and Analgesic Gel Revenue Market Share by Company in 2023
Figure 27. Global Anti-Inflammatory and Analgesic Gel Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Anti-Inflammatory and Analgesic Gel Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Anti-Inflammatory and Analgesic Gel Sales 2019-2024 (K Units)
Figure 30. Americas Anti-Inflammatory and Analgesic Gel Revenue 2019-2024 ($ millions)
Figure 31. APAC Anti-Inflammatory and Analgesic Gel Sales 2019-2024 (K Units)
Figure 32. APAC Anti-Inflammatory and Analgesic Gel Revenue 2019-2024 ($ millions)
Figure 33. Europe Anti-Inflammatory and Analgesic Gel Sales 2019-2024 (K Units)
Figure 34. Europe Anti-Inflammatory and Analgesic Gel Revenue 2019-2024 ($ millions)
Figure 35. Middle East & Africa Anti-Inflammatory and Analgesic Gel Sales 2019-2024 (K Units)
Figure 36. Middle East & Africa Anti-Inflammatory and Analgesic Gel Revenue 2019-2024 ($ millions)
Figure 37. Americas Anti-Inflammatory and Analgesic Gel Sales Market Share by Country in 2023
Figure 38. Americas Anti-Inflammatory and Analgesic Gel Revenue Market Share by Country (2019-2024)
Figure 39. Americas Anti-Inflammatory and Analgesic Gel Sales Market Share by Type (2019-2024)
Figure 40. Americas Anti-Inflammatory and Analgesic Gel Sales Market Share by Application (2019-2024)
Figure 41. United States Anti-Inflammatory and Analgesic Gel Revenue Growth 2019-2024 ($ millions)
Figure 42. Canada Anti-Inflammatory and Analgesic Gel Revenue Growth 2019-2024 ($ millions)
Figure 43. Mexico Anti-Inflammatory and Analgesic Gel Revenue Growth 2019-2024 ($ millions)
Figure 44. Brazil Anti-Inflammatory and Analgesic Gel Revenue Growth 2019-2024 ($ millions)
Figure 45. APAC Anti-Inflammatory and Analgesic Gel Sales Market Share by Region in 2023
Figure 46. APAC Anti-Inflammatory and Analgesic Gel Revenue Market Share by Region (2019-2024)
Figure 47. APAC Anti-Inflammatory and Analgesic Gel Sales Market Share by Type (2019-2024)
Figure 48. APAC Anti-Inflammatory and Analgesic Gel Sales Market Share by Application (2019-2024)
Figure 49. China Anti-Inflammatory and Analgesic Gel Revenue Growth 2019-2024 ($ millions)
Figure 50. Japan Anti-Inflammatory and Analgesic Gel Revenue Growth 2019-2024 ($ millions)
Figure 51. South Korea Anti-Inflammatory and Analgesic Gel Revenue Growth 2019-2024 ($ millions)
Figure 52. Southeast Asia Anti-Inflammatory and Analgesic Gel Revenue Growth 2019-2024 ($ millions)
Figure 53. India Anti-Inflammatory and Analgesic Gel Revenue Growth 2019-2024 ($ millions)
Figure 54. Australia Anti-Inflammatory and Analgesic Gel Revenue Growth 2019-2024 ($ millions)
Figure 55. China Taiwan Anti-Inflammatory and Analgesic Gel Revenue Growth 2019-2024 ($ millions)
Figure 56. Europe Anti-Inflammatory and Analgesic Gel Sales Market Share by Country in 2023
Figure 57. Europe Anti-Inflammatory and Analgesic Gel Revenue Market Share by Country (2019-2024)
Figure 58. Europe Anti-Inflammatory and Analgesic Gel Sales Market Share by Type (2019-2024)
Figure 59. Europe Anti-Inflammatory and Analgesic Gel Sales Market Share by Application (2019-2024)
Figure 60. Germany Anti-Inflammatory and Analgesic Gel Revenue Growth 2019-2024 ($ millions)
Figure 61. France Anti-Inflammatory and Analgesic Gel Revenue Growth 2019-2024 ($ millions)
Figure 62. UK Anti-Inflammatory and Analgesic Gel Revenue Growth 2019-2024 ($ millions)
Figure 63. Italy Anti-Inflammatory and Analgesic Gel Revenue Growth 2019-2024 ($ millions)
Figure 64. Russia Anti-Inflammatory and Analgesic Gel Revenue Growth 2019-2024 ($ millions)
Figure 65. Middle East & Africa Anti-Inflammatory and Analgesic Gel Sales Market Share by Country (2019-2024)
Figure 66. Middle East & Africa Anti-Inflammatory and Analgesic Gel Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Anti-Inflammatory and Analgesic Gel Sales Market Share by Application (2019-2024)
Figure 68. Egypt Anti-Inflammatory and Analgesic Gel Revenue Growth 2019-2024 ($ millions)
Figure 69. South Africa Anti-Inflammatory and Analgesic Gel Revenue Growth 2019-2024 ($ millions)
Figure 70. Israel Anti-Inflammatory and Analgesic Gel Revenue Growth 2019-2024 ($ millions)
Figure 71. Turkey Anti-Inflammatory and Analgesic Gel Revenue Growth 2019-2024 ($ millions)
Figure 72. GCC Countries Anti-Inflammatory and Analgesic Gel Revenue Growth 2019-2024 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Anti-Inflammatory and Analgesic Gel in 2023
Figure 74. Manufacturing Process Analysis of Anti-Inflammatory and Analgesic Gel
Figure 75. Industry Chain Structure of Anti-Inflammatory and Analgesic Gel
Figure 76. Channels of Distribution
Figure 77. Global Anti-Inflammatory and Analgesic Gel Sales Market Forecast by Region (2025-2030)
Figure 78. Global Anti-Inflammatory and Analgesic Gel Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Anti-Inflammatory and Analgesic Gel Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Anti-Inflammatory and Analgesic Gel Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Anti-Inflammatory and Analgesic Gel Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Anti-Inflammatory and Analgesic Gel Revenue Market Share Forecast by Application (2025-2030)


More Publications